Company / Return on Equity (ROE)
TELA Bio, Inc. Return on Equity (ROE) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-164.0%
FY2025
5-year range
-309.6% / -58.7%
FY2021-FY2025
Trend
+47.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
TELA Bio, Inc. reports negative total equity of -164.0% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-164.0% in FY2025 with a 3-year CAGR of -105.2%.
Remained stable around -164.0% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -105.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 47.0% year-over-year.
- Peak return on equity (roe) was recorded in FY2022.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -164.0% | +47.0% |
| FY2024 | -309.6% | -87.0% |
| FY2023 | -165.6% | -181.9% |
| FY2022 | -58.7% | +18.9% |
| FY2021 | -72.4% | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026